BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33144484)

  • 1. Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell Cancers.
    Sharma A; Babra DS; Joshi PV; Hall M; Gogbashian A; Vasdev N; Joseph M; Yazdan A; Kanfer E
    In Vivo; 2020; 34(6):3675-3679. PubMed ID: 33144484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
    Selle F; Wittnebel S; Biron P; Gravis G; Roubaud G; Bui BN; Delva R; Bay JO; Fléchon A; Geoffrois L; Caty A; Soares DG; de Revel T; Fizazi K; Gligorov J; Micléa JM; Dubot C; Provent S; Temby I; Gaulet M; Horn E; Brindel I; Lotz JP
    Ann Oncol; 2014 Sep; 25(9):1775-1782. PubMed ID: 24894084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
    Connolly EA; Weickhardt A; Grimison P; Asher R; Heller GZ; Lewin J; Liow E; Toner G; Tung ILY; Tran B; Hill S; Walpole E; McKenzie J; Kuchel A; Goh J; Forgeson G; Tan A; Joshi A; Wickham A; Tan H; Wang Y; Winstanley MA; Hamad N; Wong V
    BJU Int; 2022 Jun; 130 Suppl 1():5-16. PubMed ID: 35355402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study.
    Ferhatoglu F; Paksoy N; Khanmammadov N; Yildiz A; Ahmed MA; Gülbas Z; Basaran M
    Medicine (Baltimore); 2024 Feb; 103(8):e37213. PubMed ID: 38394499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers.
    Villela NC; Seber A; Macedo CRPD; Zecchin VG; Guimarães RFDC; Faria TMV; Vidal DO; Jorge GEM; Navarro G; Lopes LF
    Pediatr Hematol Oncol; 2023; 40(6):539-553. PubMed ID: 36940088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy for relapsed testicular germ cell tumours.
    Chovanec M; Adra N; Abu Zaid M; Abonour R; Einhorn L
    Nat Rev Urol; 2023 Apr; 20(4):217-225. PubMed ID: 36477219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
    Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N
    Cancer; 2021 Oct; 127(20):3751-3760. PubMed ID: 34260067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.
    De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M
    Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
    De Pasquale MD; D'Angelo P; Crocoli A; Boldrini R; Conte M; Bisogno G; Spreafico F; Inserra A; Biasoni D; Dall'Igna P; Siracusa F; Miele E; Terenziani M
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28125. PubMed ID: 31850649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
    Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
    Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.
    Pal SK; Yamzon J; Sun V; Carmichael C; Saikia J; Ferrell B; Frankel P; Hsu J; Twardowski P; Stein CA; Margolin K
    Clin Genitourin Cancer; 2013 Jun; 11(2):121-7. PubMed ID: 23062817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
    Kalra M; Adra N; Hanna N; Abonour R; Einhorn LH
    Cancer; 2020 Mar; 126(6):1202-1207. PubMed ID: 31743434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
    Taza F; Abonour R; Zaid MA; Althouse SK; Anouti B; Akel R; Hanna NH; Adra N; Einhorn LH
    Clin Genitourin Cancer; 2023 Apr; 21(2):213-220. PubMed ID: 36737276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Autologous Stem Cell Transplantation (ASCT) in Relapsed/Refractory Germ Cell Tumors: Single Center Experience from Turkey.
    Yildiz F; Durnali A; Eraslan E; Ilhan A; Tufan G; Aslan F; Arslan UY; Alkis N; Demirci U; Altuntas F; Oksuzoglu B
    Urol J; 2020 Aug; 17(5):497-500. PubMed ID: 32869258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose chemotherapy and stem cell rescue for metastatic germ cell tumours: long-term results from a single institution.
    Kruse V; Noens L; Lumen N; Hoebeke P; Van Belle S; Rottey S
    Acta Clin Belg; 2011; 66(4):254-9. PubMed ID: 21938979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
    Lorch A; Neubauer A; Hackenthal M; Dieing A; Hartmann JT; Rick O; Bokemeyer C; Beyer J
    Ann Oncol; 2010 Apr; 21(4):820-825. PubMed ID: 19822531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
    Al-Ezzi EM; Zahralliyali A; Hansen AR; Hamilton RJ; Crump M; Kuruvilla J; Wood L; Nappi L; Kollmannsberger CK; North SA; Winquist E; Soulières D; Hotte SJ; Jiang DM
    Curr Oncol; 2023 Jun; 30(7):6166-6176. PubMed ID: 37504318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
    Lorch A; Kleinhans A; Kramar A; Kollmannsberger CK; Hartmann JT; Bokemeyer C; Rick O; Beyer J
    J Clin Oncol; 2012 Mar; 30(8):800-5. PubMed ID: 22291076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage high-dose chemotherapy for germ cell tumors.
    Feldman DR; Powles T
    Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.